The same study also identified CDK4, an activator of E2F transcription as a modulator for E2 independent BC cell proliferation and inhibition of CDK4 led to an inhibition in the growth of fulvestrant-sensitive and -insensitive ER+ cell lines in the absence of E2 (215). This evidence concerns the gene ESR1 and breast cancer.